What’s known
- The novel coronavirus, SARS-CoV-2, has caused a global
pandemic of a life-threatening, multi-organic disease i.e., COVID-19.
- The results of the studies on COVID-19 patients have shown
that the affected patients are subject to higher risks of Diffuse
Intravascular Coagulation (DIC).
- The present study aimed to investigate the occurrence of
coagulation disorders in COVID-19 patients and determine its
relationship with the disease outcome.